866-997-4948(US-Canada Toll Free)

China Hepatitis Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 108 Pages

This report studies Hepatitis Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Vertex Pharmaceuticals
Abbvie
Achillion Pharmaceuticals
Bristol-Myers Squibb
Dynavax Technologies
Mitsubishi Tanabe Pharma

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Oral
Injection
Split by Application, this report focuses on consumption, market share and growth rate of  Hepatitis Drugs in each application, can be divided into
Hospital
Clinic

Table of Contents

1 Hepatitis Drugs Market Overview
1.1 Product Overview and Scope of Hepatitis Drugs
1.2 Hepatitis Drugs Segment by Type
1.2.1 China Production Market Share of Hepatitis Drugs Type in 2015
1.2.2 Oral
1.2.3 Injection
1.3 Applications of Hepatitis Drugs
1.3.1 Hepatitis Drugs Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Clinic
1.4 China Market Size (Value) of Hepatitis Drugs (2011-2021)
1.5 China Hepatitis Drugs Status and Outlook
1.6 Government Policies

2 China Hepatitis Drugs Market Competition by Manufacturers
2.1 China Hepatitis Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Hepatitis Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Hepatitis Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Hepatitis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hepatitis Drugs Market Competitive Situation and Trends
2.5.1 Hepatitis Drugs Market Concentration Rate
2.5.2 Hepatitis Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Hepatitis Drugs Manufacturers Profiles/Analysis
3.1 F. Hoffmann-La Roche
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Hepatitis Drugs Product Type, Application and Specification
3.1.2.1 Oral
3.1.2.2 Injection
3.1.3 F. Hoffmann-La Roche Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Gilead Sciences
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Hepatitis Drugs Product Type, Application and Specification
3.2.2.1 Oral
3.2.2.2 Injection
3.2.3 Gilead Sciences 108 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 GlaxoSmithKline
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Hepatitis Drugs Product Type, Application and Specification
3.3.2.1 Oral
3.3.2.2 Injection
3.3.3 GlaxoSmithKline 119 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Johnson & Johnson
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Hepatitis Drugs Product Type, Application and Specification
3.4.2.1 Oral
3.4.2.2 Injection
3.4.3 Johnson & Johnson Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Merck
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Hepatitis Drugs Product Type, Application and Specification
3.5.2.1 Oral
3.5.2.2 Injection
3.5.3 Merck  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Novartis
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Hepatitis Drugs Product Type, Application and Specification
3.6.2.1 Oral
3.6.2.2 Injection
3.6.3 Novartis Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Vertex Pharmaceuticals
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Hepatitis Drugs Product Type, Application and Specification
3.7.2.1 Oral
3.7.2.2 Injection
3.7.3 Vertex Pharmaceuticals Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Abbvie
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Hepatitis Drugs Product Type, Application and Specification
3.8.2.1 Oral
3.8.2.2 Injection
3.8.3 Abbvie  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Achillion Pharmaceuticals
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Hepatitis Drugs Product Type, Application and Specification
3.9.2.1 Oral
3.9.2.2 Injection
3.9.3 Achillion Pharmaceuticals  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Bristol-Myers Squibb
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Hepatitis Drugs Product Type, Application and Specification
3.10.2.1 Oral
3.10.2.2 Injection
3.10.3 Bristol-Myers Squibb  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Dynavax Technologies
3.12 Mitsubishi Tanabe Pharma

4 China Hepatitis Drugs Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
4.1 China Hepatitis Drugs Capacity, Production and Growth (2011-2016)
4.2 China Hepatitis Drugs Revenue and Growth (2011-2016)
4.3 China Hepatitis Drugs Production, Consumption, Export and Import (2011-2016)

5 China Hepatitis Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Hepatitis Drugs Production and Market Share by Type (2011-2016)
5.2 China Hepatitis Drugs Revenue and Market Share by Type (2011-2016)
5.3 China Hepatitis Drugs Price by Type (2011-2016)
5.4 China Hepatitis Drugs Production Growth by Type (2011-2016)

6 China Hepatitis Drugs Market Analysis by Application
6.1 China Hepatitis Drugs Consumption and Market Share by Application (2011-2016)
6.2 China Hepatitis Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaHepatitis Drugs Market Analysis by Regions (Provinces)
7.1 China Hepatitis Drugs Production, Production Value and Price by Regions (Provinces)(2011-2016)
7.1.1 China Hepatitis Drugs Production and Market Share by Regions (Provinces)(2011-2016)
7.1.2 China Hepatitis Drugs Production Value and Market Share by Regions (Provinces)(2011-2016)
7.1.3 China Hepatitis Drugs Sales Price by Regions (Provinces)(2011-2016)
7.2 China Hepatitis Drugs Consumption by Regions (Provinces)(2011-2016)
7.3 China Hepatitis Drugs Production, Consumption, Export and Import (2011-2016)

8 Hepatitis Drugs Manufacturing Cost Analysis
8.1 Hepatitis Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hepatitis Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Hepatitis Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hepatitis Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Hepatitis Drugs Market Forecast (2016-2021)
12.1 China Hepatitis Drugs Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Hepatitis Drugs Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Hepatitis Drugs Production Forecast by Type (2016-2021)
12.4 China Hepatitis Drugs Consumption Forecast by Application (2016-2021)
12.5 China Hepatitis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.5.1 China Hepatitis Drugs Production Forecast by Regions (Provinces)(2016-2021)
12.5.2 China Hepatitis Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
12.5.3 China Hepatitis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Hepatitis Drugs Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Hepatitis Drugs
Figure China Production Market Share of Hepatitis Drugs by Type in 2015
Figure Product Picture of Oral
Table Major Manufacturers of Oral
Figure Product Picture of Injection
Table Major Manufacturers of Injection
Table Hepatitis Drugs Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure China Hepatitis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Table China Hepatitis Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Hepatitis Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Hepatitis Drugs Capacity of Key Manufacturers in 2015
Figure China Hepatitis Drugs Capacity of Key Manufacturers in 2016
Table China Hepatitis Drugs Production of Key Manufacturers (2015 and 2016)
Table China Hepatitis Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Hepatitis Drugs Production Share by Manufacturers
Figure 2016 Hepatitis Drugs Production Share by Manufacturers
Table China Hepatitis Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Hepatitis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Hepatitis Drugs Revenue Share by Manufacturers
Table 2016 China Hepatitis Drugs Revenue Share by Manufacturers
Table China Market Hepatitis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Hepatitis Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Hepatitis Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Hepatitis Drugs Product Type
Figure Hepatitis Drugs Market Share of Top 3 Manufacturers
Figure Hepatitis Drugs Market Share of Top 5 Manufacturers
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Hepatitis Drugs Market Share (2011-2016)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Gilead Sciences Hepatitis Drugs Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Hepatitis Drugs Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Hepatitis Drugs Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Hepatitis Drugs Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Hepatitis Drugs Market Share (2011-2016)
Table Vertex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vertex Pharmaceuticals Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Vertex Pharmaceuticals Hepatitis Drugs Market Share (2011-2016)
Table Abbvie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbvie Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Hepatitis Drugs Market Share (2011-2016)
Table Achillion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Achillion Pharmaceuticals Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Achillion Pharmaceuticals Hepatitis Drugs Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Hepatitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Hepatitis Drugs Market Share (2011-2016)
Table Dynavax Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Hepatitis Drugs Capacity, Production and Growth (2011-2016)
Figure China Hepatitis Drugs Revenue (Million USD) and Growth (2011-2016)
Table China Hepatitis Drugs Production, Consumption, Export and Import (2011-2016)
Table China Hepatitis Drugs Production by Type (2011-2016)
Table China Hepatitis Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Hepatitis Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Hepatitis Drugs by Type
Table China Hepatitis Drugs Revenue by Type (2011-2016)
Table China Hepatitis Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Hepatitis Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Hepatitis Drugs by Type
Table China Hepatitis Drugs Price by Type (2011-2016)
Figure China Hepatitis Drugs Production Growth by Type (2011-2016)
Table China Hepatitis Drugs Consumption by Application (2011-2016)
Table China Hepatitis Drugs Consumption Market Share by Application (2011-2016)
Figure China Hepatitis Drugs Consumption Market Share by Application in 2015
Table China Hepatitis Drugs Consumption Growth Rate by Application (2011-2016)
Figure China Hepatitis Drugs Consumption Growth Rate by Application (2011-2016)
Table China Hepatitis Drugs Production by Regions (Provinces)(2011-2016)
Table China Hepatitis Drugs Production Market Share by Regions (Provinces)(2011-2016)
Table China Hepatitis Drugs Production Value by Regions (Provinces)(2011-2016)
Table China Hepatitis Drugs Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Hepatitis Drugs Sales Price by Regions (Provinces)(2011-2016)
Table China Hepatitis Drugs Consumption by Regions (Provinces)(2011-2016)
Table China Hepatitis Drugs Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Hepatitis Drugs Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis Drugs
Figure Manufacturing Process Analysis of Hepatitis Drugs
Figure Hepatitis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis Drugs Major Manufacturers in 2015
Table Major Buyers of Hepatitis Drugs
Table Distributors/Traders List
Figure China Hepatitis Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Hepatitis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table China Hepatitis Drugs Production, Import, Export and Consumption Forecast (2016-2021)
Table China Hepatitis Drugs Production Forecast by Type (2016-2021)
Table China Hepatitis Drugs Consumption Forecast by Application (2016-2021)
Table China Hepatitis Drugs Production Forecast by Regions (Provinces)(2016-2021)
Table China Hepatitis Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Hepatitis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)

 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *